Technology-supported Interventions for Prolonged Grief Disorder (PGD)
ConditionProlonged Grief Disorder (PGD)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitat Jaume I
About this trial
The main aim of this project is to test the efficacy of two formats of delivering an internet- based treatment(GROw) for Prolonged Grief Disorder (PGD) in order to enhance treatment adherence: in a blended format (that combines self-applied treatment online with face-to face sessions with a therapist by videoconference: BF-GROw) and self-applied online format supported by Ecological Momentary Assessment (EMAs) and Ecological Momentary Interventions (EMIs) (iGROw), compared with a waiting list (WL) control group in a community sample of patients with the diagnosis of PGD. The general initial hypothesis is that both treatment conditions (blended format and self-applied format supported by EMAs and EMIs) will significantly produce an improvement in grief symptoms, compared to the WL control group.
Eligibility criteria
Qualifiers
Being at least 18 years old.
Meeting diagnostic criteria for Prolonged Grieft Disorder based on the International Classification of Diseases 11 edition (ICD-11).
Sign an informed consent.
Ability to understand and read Spanish.
Disqualifiers
Presence of high risk of suicide.
Presence of axis I severe mental disorder: substance abuse or dependence, psychotic disorder, dementia, bipolar disorder; severe personality disorder or medical illness whose severity or characteristics prevent treatment.
Receiving other psychological treatment during the study.
An increase and/or change in the medication during the study period, in the case of receiving pharmacological treatment.
Trial design
Treatments tested in this trial
- Internet-based treatment (GROw) combined with face-to-face videoconferencing sessions with a therapist in BF-GROw group
- Internet-based treatment (GROw) supported by the App developed which contains the EMA and EMI tools in iGROw group.
Treatment groups
141 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov